OEA and LipiSperse Metabolic Study

Clinical trial NCT06840080 · COMPLETED

Trial details

NCT number: NCT06840080
Sponsor: RDC Clinical Pty Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Healthy Volunteers - Male and Female Pharmacokinetic Study in Healthy Volunteers

Start date: 2025-03-04
Primary completion: 2025-06-04
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.